The bioerodible sustained release implant technology was originally developed for ophthalmology, but the company believes it could have broader applications, such as for orthopedics.
Read the release about the partnership between pSivida and Hospital for Special Surgery.
Related Articles on Hospital for Special Surgery:
6 Ways to Build a Top Orthopedic Hospital department From Hospital for Special Srurgery’s Dr. Thomas Sculco
Hospital for Special Surgery Creates Musculoskeletal Outcomes and Research Center
Hospital for Special Surgery Researchers: Obesity Decreases Risk of Respiratory Insufficiency
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.